New research shows $5,077 in medical costs savings for dario users

Retrospective cohort study demonstrated significant reduction in medical costs for dario users with type 2 diabetes compared to non-users driven by a significant reduction in in-patient hospitalizations after one year new york , july 26, 2023 /prnewswire/ -- dariohealth corp. (nasdaq: drio) ("dario" or the "company"), a leader in the global digital health market, announced today a new analysis by sanofi us demonstrating a significant reduction in the cost of care for dario users compared to non-users living with type 2 diabetes. the study used matched claims to show an estimated $5,077 in medical cost savings for dario users compared to non-users.
DRIO Ratings Summary
DRIO Quant Ranking